CD34-selected allogeneic hematopoietic cell transplantation for chronic myeloid leukemia in the tyrosine kinase era Research Letter


Authors: Vaughn, J. L.; Brown, S.; Papadopoulos, E. B.; Jakubowski, A. A.; Tamari, R.; Giralt, S. A.; Ponce, D. M.; Cho, C.; Perales, M. A.; Shaffer, B. C.; Gyurkocza, B.
Title: CD34-selected allogeneic hematopoietic cell transplantation for chronic myeloid leukemia in the tyrosine kinase era
Keywords: adult; cancer survival; clinical article; controlled study; overall survival; outcome assessment; follow up; letter; cd34 antigen; protein kinase inhibitor; hematopoietic stem cell transplantation; protein tyrosine kinase; chronic myeloid leukemia; retrospective study; cancer mortality; protein kinase inhibitors; acute graft versus host disease; chronic graft versus host disease; graft versus host reaction; allogeneic hematopoietic stem cell transplantation; protein-tyrosine kinases; leukemia relapse; leukemia, myelogenous, chronic, bcr-abl positive; antigens, cd34; cd34 selection; log rank test; humans; human
Journal Title: Bone Marrow Transplantation
Volume: 57
Issue: 11
ISSN: 0268-3369
Publisher: Nature Publishing Group  
Date Published: 2022-11-01
Start Page: 1740
End Page: 1742
Language: English
DOI: 10.1038/s41409-022-01783-7
PUBMED: 36076011
PROVIDER: scopus
DOI/URL:
Notes: Letter -- Export Date: 1 December 2022 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Sergio Andres Giralt
    1054 Giralt
  2. Doris Ponce
    256 Ponce
  3. Miguel-Angel Perales
    918 Perales
  4. Christina Cho
    134 Cho
  5. Roni Tamari
    210 Tamari
  6. Boglarka   Gyurkocza
    136 Gyurkocza
  7. Brian Carl Shaffer
    166 Shaffer
  8. Samantha Brown
    57 Brown
  9. John Leslie Vaughn
    3 Vaughn